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D. K. F.Meii er, Summary and conclu sio ns
Summary and conclusions
The investigations described in this thesis were designed to study the mechanisms responsible for the transport of
organic cations from plasma into bile. Although still no clear cut picture of these processes can be given the
following outlines can be drawn:
A .  r u p  M o N o e U A T E R N A R y  A M M o N T U M  c o M p o u N D S
Schanker et al ( 1963, 1965) showed that the hepatic transport of procainamide thobromide (PAEB) exhibited
some characteristics of an active transport process: inhibition of biliary output by structurally related
compounds, saturation of the excretion into bile at high doses, secretion into bile against large bile-plasma
concentration gradients, and concentrative uptake into liver slices requiring energy. However, the processes
involved in uptake in the liver and excretion into bile could not be distinguished. Although the saturation of
either of these processes could not be confirmed in our studies (paper 3), the experimental results point to at
least two specialized transport processes in the liver: a concentrative uptake into the cytosol of the hepatic
parenchymal cells, and further concentration from the liver cells into bile (paper 6). During its passage through
the liver cells PAEB is partly acetylated; both the metabolite and the unchanged compound can be detected in
the bile, lever and plasma some time after injection. d-Tubocurarine and hexafluorenium, bisquaternary agents
which are highly concentrated in the bile reduced the biliary excretion of PAEB and its metabolite both in
vivo and in the isolated perfused rat liver. Although the site of inhibition could not be definitely localized,
the alteration in the ratio of free to acetylated PAEB in bile suggested interference with the transport at the
canalicular lever (paper 3). Alcuronium, a bisquaternary agent which is excreted in the bile to a small extent al-
so changed this ratio but did not affect the total amount of PAEB in bile. This may be due to a poor penetration
into the liver cells caused by its poor lipid solubility, or to a low affinity for the transport process. These data
suggest a common step in the transport of the two types of quaternary ammonium compounds although
theoretically the curares could occupy carrier sites for PAEB without being transported by this particular
transport mechanism. A dissimilar step in the hepatic transport of the mono- and bisquaternary ammonium
compounds was indicated by the finding that cardiac glycosides do not affect the transport of PAEB but are
potent blockers of the transport of some of the curares.
The.kinetics of free PAEB in the liver might be approximately described in terps of a two-compartment model:
uptake into the liver cells from the plasma compartment primarily depending on plasma concentration, and
elimination from the liver into bile depending on concentration in the cytosol of the liver cells. It was concluded
that the concentration of free and conjugated PAEB in the liver and bile were not closely related (paper 3).
However, this conclusion needs some modification: the bile concentrations were calculated from bile samples
collected over rather long periods. When these concentrations were recalculated applying corrections for mixing
of bile at 15, 30 and 60 min after injection, with bile from earlier periods, it appeared that the concentration
gradients between bile and liver for free PAEB are fairly constant in time. The values found are of the same
order as those found for bile-cytosol concentration gradient in a later study (paper 6), which is consistent with
the idea that biliary output of unchanged PAEB is directly determined by the cytosol levels. The increasing
bile-liver ratio for the conjugated substance was confirmed in the recalculations indicating a primary accumula-
tion of the acetylated PAEB in liver cells.
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B .  T H E  B I S - ( T R I S ) _ - Q U A T E R N A R Y  M M O N I U M  C O M P O U N D S
Substantial differences were found in the bil iary excretion of curare-like agents (paper 2), both in isolated
perfused rat livers and in vivo. These differences are relative rather than absolute: even the poorly excreted
curares (alcuronium, dimethyl-d-tubocurarine, gallamine and pancuronium) probably attain concentrations in
bile exceeding the plasma levels. In contrast to these agents, hexafluorenium and d-tubocurarine which are
highly concentrated in the bile are moderately l ipid soluble suggesting that this physiochemical property plays a
role in the hepatic transport. A similar relation between lipid solubil ity and excretion into bile was found by
Wasserman et al(1970) who investigated a series of hexamethonium derivates. These findings further support
the idea that a more or less crit ical balance.between polar and hydrophobic character is a prerequisite for bil iary
secretion of organic compounds (Smith, l97l). It remains to be ascertained whether l ipophil ic character is
important for penetration into the liver cells or for instance determines the affinity for carrier sites in the
canalicular membrane. The barrier between plasma and the hepatic intracellular compartment seems to be
porous to some extent and is of a lipoid nature, allowing small molecules (mol. weight < 200) and lipid soluble
substances to pass (Schanker, 1968). Large polar compounds cannot enter the liver cells in such a passive
manner and specialized uptake processes are required. In the light of the finding that d-tubocurarine
concentration in the cytosol of the l iver cells is probat l 'r lower than in plasma (paper 6) it is tempting to suggest
that passive diffusion into the hepatocytes is the primary step in the hepatic transport of the drug. However,
carrier-mediated transport is not ruled out and in both types of transport hydrophobic interactions could play a
role. That this factor is indeed important for hepatic uptake rather than for biliary excretion is supported by
our observations that the rate of clearance of hexafluorenium, which is more lipid-soluble than d-tubocurarine,
is much greater than that of d-tubocurarine while the extent of excretion into bile is of the same order.
Especially in the case of hexafluorenium, uptake into the liver and elimination via the bile, both following
first-order kinetics, show very different half-lives (paper 5). This indicates that uptake into the liver and
excretion into bile occurs from different compartments, which in turn implies that at least two separate
processes are involved.
There are few species variations in the biliary excretion of organic compounds with a molecular weight higher
than 500 (Smith, I97l). This is confirmed by our Íinding that hexafluorenium is highly concentrated in the bile
of postcholecystectomized patients as well (paper 4). Excretion data from the literature (see introduction) of
the other curare-like drugs in various species generally parallel the excretion pattern in the rat. Among the
muscle relaxants frequently used clinically, d-tubocurarine and hexafluorenium (the latter combined with
suxamethonium which is rapidly hydrolysed) are therefore drugs of choice in the case of renal faiture, since
elimination via the bile offers an alternative exretory parthway.
Of particular interest is the finding that cardiac glycosides interfere with transport from plasma into bile of
hexafluorenium and d-tubocurarine. The extremely rapid uptake of hexafluorenium made it possible to design
experiments in which the cardiac-glycoside-sensitive step was shown to be localized at the level of uptake of the
drug into the liver cells rather than * the level of biliary excretion (paper 5). The manner in which
K-strophantoside alters the distribution of d-tubocurarine suggest that it influences uptake into some compart-
ment or organelle inside the liver cells, which in somehow related to the biliary excretion process (paper 6). The
action of the cardiac glycosides which are also accumulated in the rat liver (Kupferberget al, 1968, 1969) is
possibly related to inhibition of Na*, K+ activated ATP-ase in the liver leading to an influence on energy supply, or
to a chauge in Na+ and K+ concentration gradients. However, it should be kept in mind that the action of these
metabolic inhibitors may not be entirely restricted to the particular biochemical process they are presumed to
inhibit.
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The following tentative scheme can be presented in summary. At least two and perhaps three processes may
play a role in the transport of the bisquaternary ammonium compounds:
a) uptake into the liver cells by either passive diffusion or some specialized process in which hydrophobic
features are important,
b) uptake into some compartment inside the cell which can be inhibited by cardiac glycosides
c) concentrative transfer into bile possibly related to b).
In the future a multiple experimental approach including in vivo studies, liverperfusions, experiments with
subcellular organelles and cellular autoradiographic studies, will be required for further elucidation of the
critical steps involved in the hepatic uptake and biliary elimination of drugs.
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